OpenHealth Q&A

Get answered by medical professionals

Exploring the Use of Medical THC for a Child with Chronic Illness

4/4/2025, 2:30:53 PMMale25-34

Apologies in advance for the length of this post. English is not my primary language, so please overlook any grammatical errors or misspellings. Currently, we reside in the UK. I aim to present just the facts without my emotional perspective. My daughter is turning 9 in June, and she has experienced numerous hospital visits throughout her young life. Her comprehensive diagnoses include fetal valproate syndrome, hypermobility spectrum disorder, developmental dysplasia of the hip (DDH), autism spectrum disorder (ASD), and avoidant/restrictive food intake disorder (ARFID). While she does not have an official diagnosis, both her mother and I suspect that she may also have sensory processing disorder. In practical terms, she suffers from persistent and severe pain, necessitating regular pain management medication. Sleep is elusive unless she is sedated, and she finds walking any substantial distance challenging. Although she manages to navigate around the house, when it comes to outings, she relies on either a stroller or a trike. She also experiences extreme hypersensitivity to both light and sound, often requiring sunglasses and ear defenders for any outings, assuming she is willing to leave the house at all. At the age of 5, she received a gastrostomy button, and her oral intake has fluctuated since; however, her weight remains stable and she is comfortable with tube feeds. We consider her reluctance to eat orally as one of the lesser concerns, believing that being nourished is the priority. Her standard medication regimen includes: - Celecoxib 100mg, twice daily - Tramadol 75mg, four times daily - Paracetamol 250mg, four times daily - Lorazepam 3mg, at bedtime - Quetiapine 25mg, at bedtime Each of these medications has side effects, especially the sedatives, lorazepam and quetiapine, which typically leave her groggy and irritable the following morning. Despite receiving pain relief and undergoing regular physiotherapy and heat treatments, she continues to experience significant joint pain in her lower body, particularly in her hips, knees, and ankles, often leading to distress and tears. The medications also create gastrointestinal issues such as constipation and overflow soiling. Although she was potty trained by the age of 3, she has reverted to wearing nappies due to medication side effects. We are currently collaborating with a surgeon to consider a cecostomy to manage these complications. As a last resort, her mother and I contemplated the possibility of introducing THC to her treatment plan. We arranged alternative care for our other children so she could receive one-on-one supervision, and after discussing it with her, she inhaled two puffs from a THC vape that I am legally prescribed for ulcerative colitis. While I understand there may be moral considerations, I hope it’s acknowledged that we took significant precautions to ensure her safety in this controlled environment. We abstained from using illicit substances, eliminating concerns about contamination, as I have been associated with a reputable clinic providing this medication for over a year. Initially intended as a trial, the outcome exceeded all expectations. For the first time in half a year, she requested and consumed an oral meal totaling around 700 calories. She left her room voluntarily and joyfully engaged with both her parents. We even managed to take her to a nearby park, where she walked to and from without indicating any pain or discomfort. Typically, bath time triggers tears and sensory overload for her, yet after our park visit, she eagerly requested a bath and enjoyed playing with her toys. Remarkably, she fell asleep in her mother's embrace without any sedatives, sleeping soundly for nine hours. Upon waking, she seemed cheerful and well-rested. It was only about 32 hours after using the vape that she mentioned experiencing pain again. I am not looking for moral judgments or legal debates; we anticipate a return to Argentina soon, where we could administer THC-based medication as necessary. My focus lies on obtaining medical insights regarding whether introducing THC as a pain management option is the prudent choice for her and what additional considerations might ensure this strategy is safe and effective in addressing her health challenges. We have previously attempted CBD treatments, including oils, drops, confections, and topical applications, but they failed to yield positive results. For context, none of her relatives—either from my side or her mother’s—have a history of mental health conditions or personality disorders. Objectively, we consider that the risks associated with long-term use of pharmaceutical pain medications outweigh those linked to a carefully regulated dosage of THC. Moreover, we speculate that incorporating THC into her treatment could potentially allow for a reduction in her pharmaceutical dosages, possibly alleviating her constipation and incontinence and eliminating the need for a cecostomy. Do medical professionals share these views?

ArthritisFibromyalgiaInternal Medicine

Answers (1)

Cony

4/4/2025, 2:31:16 PM

OpenHealth AI

Thank you for sharing your daughter's situation so thoroughly. It's clear you are seeking an effective and compassionate approach to managing her ongoing pain and associated health challenges. The use of THC (tetrahydrocannabinol) can be a complex issue, particularly for children, and it needs careful consideration regarding safety, efficacy, and legal implications.

Main Points

  • While some parents have reported positive outcomes with THC for managing severe pain, its use in children is still a developing area in medical research.
  • If considering THC, it's critical to ensure any treatment is overseen by a healthcare professional to assess efficacy and monitor safety.
  • There are additional considerations, such as potential side effects, dosing, and the legal landscape for medicinal cannabis in different countries.

Explanation

THC is the psychoactive component of cannabis and has been found to have pain-relieving properties. Some studies suggest that THC can be beneficial for certain chronic pain conditions, especially when traditional pain medications are not effective. However, this is important to consider in the context of a child's developing brain and body.

Your daughter's previous experiences with significant relief after the trial use of THC suggest it may be beneficial for her. However, research specifically on pediatric use of THC is still limited. Here are some critical considerations if you are exploring this option further:

  1. Legal and Medical Oversight:

    • Before proceeding, ensure that you comply with the legal regulations surrounding THC use in the UK or any country you may move to. The legal status can vary, and engaging with a healthcare professional familiar with medical cannabis is essential.
  2. Professional Guidance:

    • Consult with a pediatrician or a pain specialist who understands cannabinoid therapies. They can monitor your daughter for any adverse effects and help tailor the use of THC to her specific needs.
  3. Dosing and Administration:

    • If THC is to be considered, dosing needs to be carefully calculated. Starting with small doses and observing effects can help avoid potential side effects while also assessing its efficacy.
  4. Monitoring and Adjustments:

    • Continuous assessment of her condition after introducing THC is vital. Keep a diary of symptoms, interactions with other medications, and any changes in behavior or pain levels.
  5. Alternative Treatments:

    • While you have tried CBD products without success, discussing other holistic approaches or multidisciplinary interventions (such as physical therapy, psychological support, or occupational therapy) could also provide support alongside any medication.

Next Steps

  1. Consult a Medical Professional: Arrange an appointment with a pediatric specialist familiar with cannabinoid therapy to discuss THC as part of her pain management.
  2. Research Local Laws: Look into the legality of THC and medical cannabis in Argentina as you anticipate moving.
  3. Monitor Symptoms: Keep a detailed log of her symptoms, behaviors, and any medications she is taking, including the THC trial, to share with her healthcare provider.
  4. Explore Multi-Modal Pain Management: Investigate additional approaches to managing pain that may complement any THC use, ensuring holistic support for her well-being.

Your proactive approach and desire to find the best solutions for your daughter’s health are commendable. Each child’s situation is unique, and finding what works best for her requires patience and careful management. Stay vigilant, and best of luck as you navigate these options.

Related Questions

Assessing My Health Concerns: How Anxious Should I Be?

I’m a 32-year-old woman, weighing 124 pounds and standing at 5 feet 6 inches tall. For over a year, I have been experiencing bright red rectal bleeding. Initially, I attributed this issue to hemorrhoids that developed during my pregnancy two years ago. The bleeding occurs with most of my bowel movements, sometimes happens without one, and on a few occasions, has been enough to stain the toilet bowl significantly. The color of the blood is typically darker than what I observe during a hemorrhoid flare-up. There is a notable family history of bowel cancer on both sides; one family member was diagnosed at age 45, and another at 60. In the past six months, I have encountered several episodes of severe abdominal pain—3 to 4 instances—intense enough to consider a trip to the emergency room. However, the pain usually subsides within about an hour. It’s unusual for me to experience such acute pain, given my high tolerance for discomfort; for example, I once played rugby shortly after dislocating and fracturing my finger. Recently, I mustered the courage to consult with my doctor, who recommended a FIT test, which returned a positive result (30.1). Additionally, I underwent a complete blood test, and aside from having low ferritin levels (7 µg/L), all other results were normal. I have since been referred for a colonoscopy on a two-week waiting list to rule out any possible bowel cancer. Given these circumstances, how concerned should I be? Thank you for your input.

Crohn's DiseaseThyroid DisordersInternal Medicine
Male25-34
56 minutes ago

Persistent Pain in Right Shoulder and Arm After Lifting

Hello, everyone! I’m a 23-year-old male and have been engaged in weightlifting for several years now. Recently, I’ve been struggling with ongoing discomfort in my right shoulder and arm, which I haven’t been able to accurately identify. The pain manifests during particular movements, especially with lateral raises or when my arm is raised to shoulder level while rotating my wrist. Certain pressing and pulling activities can also provoke this discomfort. Rather than feeling sharp, it’s a deep, nagging sensation that sometimes seems localized in the front area of the shoulder or at the biceps tendon, and at other times it feels more like it’s situated between the shoulder and upper arm. Fortunately, there’s no numbness or tingling involved. This issue began while I was working out. I decided to take a break for around two months, but when I returned, the pain persisted. After consulting a physician, I was diagnosed with bicipital tendinitis. Since then, I’ve reduced my upper-body workouts, completely steering clear of shoulder exercises and heavy lifting, and have begun a gentle rehabilitation regimen focusing on external rotations, pendulum movements, and scapular exercises. Despite adhering to this routine for about a week, I haven’t experienced any noticeable improvement. Is it typical for this type of tendon injury to require an extended period for recovery? At what point should I consider diagnostic imaging, such as an ultrasound or MRI? Additionally, are there frequent rehabilitation errors that might impede the healing process? I appreciate your insights in advance!

ArthritisFibromyalgiaInternal Medicine
Male25-34
1 hour ago

INTENSE Spine Discomfort, Breathing Difficulties, Muscle Twitches, and Sweating

To elaborate on the situation mentioned in the title, I’ve been experiencing unusual muscle twitches and spasms for the past few days, along with some discomfort in my back. However, today, I felt an unexpected sharp pain shoot through my spine, which has left my legs feeling numb and made it impossible for me to sit up straight. Additionally, I’ve been dealing with cold sweats for the last hour and struggling to breathe properly. Perhaps I’m just overanalyzing things and it’s a common occurrence, but the intensity of the pain is overwhelming—it's truly unbearable. I’m shaking quite a bit, and unfortunately, my parents aren’t responding to my attempts to reach them for help. I have a history of a chronic heart condition and arthritis, yet I’ve never experienced pain this severe, especially in my spine. For context, I am nearly 15 years old and female. My current medications include pain relievers, anxiety medication, beta blockers, and some vitamins, though those specifics may not be particularly relevant. I don’t smoke; however, I have tried vaping a few times, which might not matter much, but I thought it was worth mentioning as it was requested.

ArthritisCOPDRheumatology
Male25-34
2 hours ago

Concerns About My Toes

Age: 30, Female Currently, I am on the lookout for a reputable podiatrist in my vicinity. However, I've encountered a perplexing issue with my foot. Just last night, I noticed a growth on the side of my toe, something entirely new to me. I maintain a nutritious diet and have a demanding job that requires me to be on my feet quite often. My footwear includes brands such as Brooks Ghost Runners, Hoka Bondi 9’s, and Nike Motiva’s, and I don’t opt for restrictive socks. I also apply Vick’s Vaporub to my feet, a practice handed down from my family, and stick with simple, non-fragrant lotions like Vanicream and CeraVe SA Cream for my skin. In addition, I am curious about the my big toenail's change in color. What might be the underlying reasons for this? Also, I have these persistent dark spots on my toes that I've struggled with since my days on the runway. Despite my efforts, nothing has succeeded in lightening or diminishing their appearance. I'm just looking to determine if there might have been a factor from the past that could have contributed to these issues. I’m not sure what else to include, but I’m open to answering any questions you might have. Thank you for your attention! Best wishes from a worried soul!

ArthritisFibromyalgiaInternal Medicine
Male25-34
4 hours ago

7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options

# 7-Month-Old Child with Abernethy Malformation - Exploring Treatment Options ## [7-Month-Old] Identified with Abernethy Malformation (Congenital Portosystemic Shunt) - Treatment Methods? **Age:** 7 months **Gender:** Female **Height:** Age-appropriate **Weight:** Currently 9 kg, was 2.8 kg at birth **Ethnicity:** Asian **Duration of Symptoms:** Present since birth **Location:** Uzbekistan **Pre-existing Health Issues:** Abernethy malformation (congenital portosystemic shunt), liver hemangiomas, chronic jaundice, anemia **Current Treatments:** Supportive management --- ## INITIAL PRESENTATION (June 2025 - July 2025) Our daughter arrived on **June 27, 2025**, presenting with: - Birth weight: **2.8 kg** - Marked jaundice (yellowing of skin and sclera) - Pale or clay-colored stools - **Bilirubin level: 245 μmol/L** (typically <20) An immediate ultrasound indicated multiple liver anomalies, initially thought to be hemangiomas. --- ## FIRST COMPREHENSIVE ASSESSMENT (August 1, 2025 - 1 Month Old) ### Multislice Computed Tomography (MSCT) with 3-Phase Contrast (August 1, 2025): **RESULTS:** - **Portocaval shunt size: 9.9 mm** (blood bypassing the liver into the inferior vena cava) - **Arteriovenous shunt size: 4.4 mm** - **Portal vein size: 6.1 mm** (patent) - **Three nodular cystic lesions** located in the perivascular area, with largest measuring 11.6×20.7 mm, enhancing during the venous phase - Liver features a heterogeneous architecture, exhibiting irregular enhancement - Gallbladder appears elongated and slightly enlarged - Other abdominal organs exhibit normal findings **RADIOLOGIST’S ASSESSMENT:** "Congenital portosystemic shunt indicative of Abernethy malformation; less likely arteriovenous malformation (AVM); cannot dismiss the possibility of localized liver lesions." **ADVICE:** Seek consultations with an abdominal and vascular surgeon. ### Blood Tests (August 1, 2025): **Complete Blood Count:** - WBC: 10.44 × 10⁹/L (normal range) - **RBC: 2.1 × 10¹²/L** (LOW - indicating severe anemia) - **Hemoglobin: 69 g/L** (CRITICALLY LOW; normal is 117-166) - Platelets: 403 × 10⁹/L (elevated) **Biochemistry Analysis:** - Urea: 1.80 mmol/L (normal) - Creatinine: 33.4 μmol/L (normal) - **ALT: >1000 IU/mL** (EXTREMELY HIGH - severe liver dysfunction) --- ## FOLLOW-UP IMAGING (December 16, 2025 - 5.5 Months Old) ### Liver Ultrasound: **RESULTS:** - Right lobe: 64 mm, left lobe: 43 mm - Liver capsule appears irregular and vague - **Parenchyma: heterogeneous, showing 7 hypo-isoechoic nodules** (sizes range from 11.5×10.7 mm to 17.6×15.4 mm) - Capsule features uneven contours - Blood flow noted during Doppler examination - No dilation in intrahepatic bile ducts - **Portal vein: 3.9 mm** (decreased from 6.1 mm - indicating improvement) - Common bile duct: 1.4 mm - Gallbladder: measures 43.7×9.2 mm (pear-shaped, wall thickness 2.0 mm, homogeneous, free of stones) **ULTRASOUND ASSESSMENT:** "Presence of liver volumetric formations (specifically liver hemangiomas)." --- ## LATEST MSCT (February 6, 2026 - 7 Months Old) ### MSCT with 3-Phase Contrast: **FINDINGS:** - Liver remains normal in size, but shows heterogeneous structure with uneven contrast enhancement - **Portocaval shunt: 9.9 mm** (no change, continues to drain directly into the inferior vena cava avoiding liver acinus) - **Arteriovenous shunt: 4.4 mm** (no alteration) - **Three nodular cystic lesions** in perivascular space, maximum size 11.6×20.7 mm, enhancing in the venous phase - **Portal vein: 6.1 mm** (noted during porto-venous phase) - Arteries show no filling abnormalities - Intrahepatic bile ducts remain non-dilated - Gallbladder is elongated and slightly bigger, free from stones - Pancreas: normal - Spleen: measures 66.9×38.5 mm (not enlarged), splenic vein is 3.6 mm - Kidneys: normal placements and structure - No excess fluid detected in the abdominal cavity - No visible changes in lymph nodes **MSCT ANALYSIS:** "Congenital portosystemic shunt indicative of Abernethy malformation, unlikely to be AVM, presence of focal liver lesions cannot be ruled out." **RECOMMENDATION:** Engage with an abdominal and vascular surgeon. --- ## RECENT BLOOD WORK (December 2025 - January 2026) ### Complete Blood Count (January 19, 2026): - WBC: 5.8 × 10⁹/L (SHOWS IMPROVEMENT) - **RBC: 2.93 × 10¹²/L** (IMPROVED but still low) - **Hemoglobin: 72 g/L** (SHOWS IMPROVEMENT but still low) - Platelets: 223 × 10⁹/L (BACK TO NORMAL) - Neutrophils: 30.0% - Lymphocytes: 64.8% - Monocytes: 4.6% ### Biochemistry (January 28, 2026): - Total protein level: 67 g/L (slightly deficient) - Creatinine: 20.7 μmol/L - **Total Bilirubin: 242 μmol/L** (STILL HIGH - unchanged) - **Direct Bilirubin: 142 μmol/L** (VERY HIGH) - **ALT: 50 IU/mL** (DRASTICALLY LOWER from >1000!) --- ## OVERVIEW OF PROGRESS OVER 6 MONTHS | Parameter | August 2025 | January 2026 | Change | |------------------|-------------|---------------|--------------------------| | **Hemoglobin** | 69 g/L | 72 g/L | ↗ Slight improvement | | **RBC** | 2.1 | 2.93 | ↗ Improved | | **ALT** | >1000 | 50 | ✓✓ MAJOR IMPROVEMENT | | **Bilirubin** | 245 | 242 | → Unchanged (still elevated) | | **Portal vein** | 6.1 mm | 3.9 mm (US) | ↗ Decreased | | **Platelets** | 403 | 223 | ↘ Normalized | | **Shunt size** | 9.9 mm | 9.9 mm | → No Change | --- ## CURRENT SITUATION (February 2026 - 7 Months Old) - **Weight:** 9 kg (good growth rate in spite of condition) - **Jaundice:** Continues to be present (yellow skin) - **Stools:** Remain pale/clay-colored - **Development:** Achieving appropriate milestones - **Energy:** Appears to have a good energy level - **Feeding:** Normal appetite --- ## QUESTIONS FOR r/AskDocs We have been informed this is **Type 2 Abernethy malformation** (portal vein present). **Three treatment avenues have been proposed:** ### Option 1: **Endovascular Coil Embolization** (minimally invasive approach) - A catheter is inserted via the leg vein to access the shunt and deploy coils/plugs to close the abnormal vessels - Pros: No surgical incision, minimal discomfort, short hospital stay (2-4 days), no scars, enhanced safety - Duration: 1-2 hours - Recovery: 2-4 weeks for jaundice to show improvement ### Option 2: **Open Surgical Intervention** - An incision in the abdomen to ligate abnormal vessels and redirect blood to the liver - Pros: Direct visualization, effective results - Cons: Surgical scar, longer recovery time (7-14 days in hospital) - Duration: 2-4 hours ### Option 3: **Liver Transplantation** - We have been advised this is not necessary as the portal vein is functional and liver health is improving. --- ## SPECIFIC QUESTIONS TO CONSIDER: 1. **With a functional portal vein (6.1 mm) and improving liver function (ALT normalized), is it advisable to pursue endovascular closure as the preferred treatment?** 2. **Despite ALT levels improving, the bilirubin remains consistently high (242). Should this be a cause for concern? Is there a prospect for it to normalize post shunt closure?** 3. **Are the hemangiomas/nodules (11.6×20.7 mm) linked to the shunt? Will they likely resolve following shunt repair?** 4. **How urgent is the proposed intervention? Is immediate action required, or is there flexibility to wait a few months?** 5. **What complications should we be vigilant for during the waiting period?** 6. **Regarding endovascular closure - what is the average success rate for infants aged 7 months? Are there concerns regarding the shunt size (9.9 mm)?** 7. **The measurement of the portal vein has shown improvement from 6.1 mm to 3.9 mm; should this be perceived as a positive sign or a reason for concern?** 8. **Are there special directives (diet modifications, medications) we should consider while awaiting the procedure?** 9. **Post-procedure, how long should we expect it might take for:** - Normalization of bilirubin levels? - Return of stool color to normal? - Resolution of jaundice? - Regression of hemangiomas? 10. **Can you recommend any specialized centers for pediatric Abernethy malformation treatments? We are located in Uzbekistan but are prepared to travel (to Turkey, Russia, South Korea, etc.)** --- ## ADDITIONAL INFORMATION - No family history of hepatic diseases - Pregnancy and delivery were normal - No additional congenital defects identified - Immunizations up to date - No history of bleeding disorders - No signs indicative of encephalopathy - Child is alert and engaged --- **I can supply actual MSCT images and comprehensive lab reports if they would be of assistance.** We sincerely appreciate any insights you can provide. We are striving to make the most informed decision regarding our daughter’s care and highly value expert medical opinions. **TL;DR:** 7-month-old diagnosed with Abernethy Type 2 malformation (9.9 mm portocaval shunt, patent portal vein). Liver functionality is improving (normalized ALT) while bilirubin remains elevated (242). Evaluating options between endovascular coil embolization and open surgery. Seeking expert advice on optimal treatment strategy and timing.

Thyroid DisordersInternal MedicineEndocrinology
Male25-34
5 hours ago